MOTION Clinical Trial for Knee Osteoarthritis

The MOTION Clinical Trial is studying a new device called the MISHA Knee System for people with osteoarthritis (wear and tear) in their knee. This device is an implant designed to reduce pressure on the inner part of the knee. The study will compare the MISHA Knee System to non-surgical treatments like physical therapy, medications, and injections. You might be able to join if you have knee pain mainly on the inner side, a WOMAC pain score of 40 or higher, and haven't found relief from other treatments. The main goal is to see how much your knee pain improves after 6 months, as measured by the WOMAC Pain score. The current status of this study is unclear, and it plans to enroll 100 participants.

Study design
This is a randomized controlled trial, meaning participants will be randomly assigned to receive either the MISHA Knee System or non-surgical treatment. There will be 100 participants in total.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 6 months, which suggests follow-up for at least that long after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06843980

MOTION Clinical Trial

Recruiting
NAAll AgesInterventionalTreatment
Moximed
~100 participants
Updated 2026-07-14 on ClinicalTrials.gov
What's tested:MISHA Knee SystemNon-Surgical Treatment

At a glance

Recruiting sites
6 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
WOMAC Pain at 6 Months
Measured over 6 Months
Osteoarthritis, Knee
9 sites across 6 states
California3
Illinois2
Nebraska1
New York1
Ohio1
Texas1
  • Rose S Weinstein · STUDY_DIRECTOR · Moximed

Opens a ready-to-send draft in your own email app — review before sending.

  • WOMAC Pain at 6 Months6 Months

    Improvement in WOMAC Pain in the MISHA arm compared to the non-surgical arm measured on the initial cohort who complete the 6-month follow-up visit